{"nctId":"NCT00996307","briefTitle":"Pivotal, Multicenter, Observer-Blind, Randomized Study of Influenza A (H1N1)2009 Monovalent Subunit Vaccine With and Without Adjuvant in Children Ages 6 to <36 Months","startDateStruct":{"date":"2009-10"},"conditions":["Influenza"],"count":654,"armGroups":[{"label":"3.75_(50)MF59","type":"EXPERIMENTAL","interventionNames":["Biological: MF59-eH1N1_f"]},{"label":"7.5_(0)MF59","type":"EXPERIMENTAL","interventionNames":["Biological: MF59-eH1N1_f"]},{"label":"7.5_(50)MF59","type":"EXPERIMENTAL","interventionNames":["Biological: MF59-eH1N1_f"]},{"label":"15_(0)MF59","type":"EXPERIMENTAL","interventionNames":["Biological: MF59-eH1N1_f"]}],"interventions":[{"name":"MF59-eH1N1_f","otherNames":[]},{"name":"MF59-eH1N1_f","otherNames":[]},{"name":"MF59-eH1N1_f","otherNames":[]},{"name":"MF59-eH1N1_f","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Children 6 to 35 months of age in good health as determined by medical history, physical assessment and clinical judgement of the investigator and without influenza within the past 6 months\n\nExclusion Criteria:\n\n* History of serious disease.\n* History of serious reaction following administration of vaccine or hypersensitivity to vaccine components.\n* Known or suspected impairment/alteration of immune function.\n* Receipt or planned receipt of seasonal trivalent influenza vaccine within 1 week before or after each study vaccination\n\nFor additional entry criteria, please refer to protocol","healthyVolunteers":true,"sex":"ALL","minimumAge":"6 Months","maximumAge":"35 Months","stdAges":["CHILD"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Antibody Responses After the First and Second Vaccinations","description":"CBER guidance (\\<65 years of age): The lower bound of the two-sided 95% CI for the percent of subjects achieving seroconversion for HI antibody should be ≥ 40% AND the lower bound of the two sided 95% CI for the percent of subjects achieving an HI antibody titer ≥ 1:40 should be ≥ 70%.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"19","spread":null},{"groupId":"OG001","value":"9","spread":null},{"groupId":"OG002","value":"15","spread":null},{"groupId":"OG003","value":"19","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"79","spread":null},{"groupId":"OG001","value":"37","spread":null},{"groupId":"OG002","value":"86","spread":null},{"groupId":"OG003","value":"50","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"74","spread":null},{"groupId":"OG001","value":"32","spread":null},{"groupId":"OG002","value":"80","spread":null},{"groupId":"OG003","value":"44","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"100","spread":null},{"groupId":"OG001","value":"70","spread":null},{"groupId":"OG002","value":"100","spread":null},{"groupId":"OG003","value":"81","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"98","spread":null},{"groupId":"OG001","value":"68","spread":null},{"groupId":"OG002","value":"98","spread":null},{"groupId":"OG003","value":"76","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"96","spread":null},{"groupId":"OG001","value":"50","spread":null},{"groupId":"OG002","value":"100","spread":null},{"groupId":"OG003","value":"55","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"89","spread":null},{"groupId":"OG001","value":"50","spread":null},{"groupId":"OG002","value":"91","spread":null},{"groupId":"OG003","value":"39","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"85","spread":null},{"groupId":"OG001","value":"27","spread":null},{"groupId":"OG002","value":"84","spread":null},{"groupId":"OG003","value":"36","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"76","spread":null},{"groupId":"OG001","value":"22","spread":null},{"groupId":"OG002","value":"76","spread":null},{"groupId":"OG003","value":"25","spread":null}]}]}]},{"type":"SECONDARY","title":"Immunogenicity Measurement by Geometric Mean Titers (GMT)","description":"Immunogenicity was measured in terms of the GMT at 21 days after each vaccination.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"10","spread":null},{"groupId":"OG001","value":"7.27","spread":null},{"groupId":"OG002","value":"9.29","spread":null},{"groupId":"OG003","value":"11","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"83","spread":null},{"groupId":"OG001","value":"20","spread":null},{"groupId":"OG002","value":"92","spread":null},{"groupId":"OG003","value":"37","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"642","spread":null},{"groupId":"OG001","value":"80","spread":null},{"groupId":"OG002","value":"626","spread":null},{"groupId":"OG003","value":"151","spread":null}]}]}]},{"type":"PRIMARY","title":"Number of Participants Reporting Solicited Local and Systemic Reactions After First Vaccination","description":"Safety was measured in terms of the number of participants reporting solicited local and systemic reactions after first vaccination.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null},{"groupId":"OG001","value":"0","spread":null},{"groupId":"OG002","value":"0","spread":null},{"groupId":"OG003","value":"0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1","spread":null},{"groupId":"OG001","value":"0","spread":null},{"groupId":"OG002","value":"2","spread":null},{"groupId":"OG003","value":"1","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"6","spread":null},{"groupId":"OG001","value":"9","spread":null},{"groupId":"OG002","value":"4","spread":null},{"groupId":"OG003","value":"6","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"8","spread":null},{"groupId":"OG001","value":"8","spread":null},{"groupId":"OG002","value":"13","spread":null},{"groupId":"OG003","value":"8","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"49","spread":null},{"groupId":"OG001","value":"42","spread":null},{"groupId":"OG002","value":"53","spread":null},{"groupId":"OG003","value":"42","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"36","spread":null},{"groupId":"OG001","value":"28","spread":null},{"groupId":"OG002","value":"38","spread":null},{"groupId":"OG003","value":"30","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"32","spread":null},{"groupId":"OG001","value":"28","spread":null},{"groupId":"OG002","value":"37","spread":null},{"groupId":"OG003","value":"25","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"13","spread":null},{"groupId":"OG001","value":"10","spread":null},{"groupId":"OG002","value":"12","spread":null},{"groupId":"OG003","value":"10","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"40","spread":null},{"groupId":"OG001","value":"39","spread":null},{"groupId":"OG002","value":"45","spread":null},{"groupId":"OG003","value":"41","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"21","spread":null},{"groupId":"OG001","value":"16","spread":null},{"groupId":"OG002","value":"19","spread":null},{"groupId":"OG003","value":"18","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"34","spread":null},{"groupId":"OG001","value":"35","spread":null},{"groupId":"OG002","value":"35","spread":null},{"groupId":"OG003","value":"35","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"5","spread":null},{"groupId":"OG001","value":"5","spread":null},{"groupId":"OG002","value":"9","spread":null},{"groupId":"OG003","value":"7","spread":null}]}]}]},{"type":"PRIMARY","title":"Number of Participants Reporting Solicited Local and Systemic Reactions After Second Vaccination","description":"Safety was measured in terms of the number of participants reporting solicited local and systemic reactions after second vaccination.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null},{"groupId":"OG001","value":"0","spread":null},{"groupId":"OG002","value":"1","spread":null},{"groupId":"OG003","value":"0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1","spread":null},{"groupId":"OG001","value":"1","spread":null},{"groupId":"OG002","value":"4","spread":null},{"groupId":"OG003","value":"1","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2","spread":null},{"groupId":"OG001","value":"1","spread":null},{"groupId":"OG002","value":"8","spread":null},{"groupId":"OG003","value":"6","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"4","spread":null},{"groupId":"OG001","value":"3","spread":null},{"groupId":"OG002","value":"12","spread":null},{"groupId":"OG003","value":"9","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"35","spread":null},{"groupId":"OG001","value":"27","spread":null},{"groupId":"OG002","value":"37","spread":null},{"groupId":"OG003","value":"32","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"28","spread":null},{"groupId":"OG001","value":"21","spread":null},{"groupId":"OG002","value":"20","spread":null},{"groupId":"OG003","value":"17","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"20","spread":null},{"groupId":"OG001","value":"19","spread":null},{"groupId":"OG002","value":"20","spread":null},{"groupId":"OG003","value":"15","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"11","spread":null},{"groupId":"OG001","value":"9","spread":null},{"groupId":"OG002","value":"14","spread":null},{"groupId":"OG003","value":"5","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"36","spread":null},{"groupId":"OG001","value":"39","spread":null},{"groupId":"OG002","value":"32","spread":null},{"groupId":"OG003","value":"24","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"20","spread":null},{"groupId":"OG001","value":"18","spread":null},{"groupId":"OG002","value":"14","spread":null},{"groupId":"OG003","value":"11","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"21","spread":null},{"groupId":"OG001","value":"22","spread":null},{"groupId":"OG002","value":"24","spread":null},{"groupId":"OG003","value":"18","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"8","spread":null},{"groupId":"OG001","value":"5","spread":null},{"groupId":"OG002","value":"4","spread":null},{"groupId":"OG003","value":"7","spread":null}]}]}]},{"type":"SECONDARY","title":"Antibody Responses With and Without Seasonal Influenza Vaccination for Year 2009 to 2010","description":"Subgroup analysis based on receipt of recent seasonal vaccination. Comparison between subjects previously vaccinated versus not vaccinated with seasonal influenza vaccines.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"73","spread":null},{"groupId":"OG001","value":"37","spread":null},{"groupId":"OG002","value":"78","spread":null},{"groupId":"OG003","value":"44","spread":null},{"groupId":"OG004","value":"75","spread":null},{"groupId":"OG005","value":"22","spread":null},{"groupId":"OG006","value":"85","spread":null},{"groupId":"OG007","value":"45","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"99","spread":null},{"groupId":"OG001","value":"66","spread":null},{"groupId":"OG002","value":"98","spread":null},{"groupId":"OG003","value":"78","spread":null},{"groupId":"OG004","value":"96","spread":null},{"groupId":"OG005","value":"71","spread":null},{"groupId":"OG006","value":"100","spread":null},{"groupId":"OG007","value":"73","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"25","spread":null},{"groupId":"OG001","value":"12","spread":null},{"groupId":"OG002","value":"16","spread":null},{"groupId":"OG003","value":"21","spread":null},{"groupId":"OG004","value":"8","spread":null},{"groupId":"OG005","value":"2","spread":null},{"groupId":"OG006","value":"12","spread":null},{"groupId":"OG007","value":"15","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"78","spread":null},{"groupId":"OG001","value":"42","spread":null},{"groupId":"OG002","value":"84","spread":null},{"groupId":"OG003","value":"49","spread":null},{"groupId":"OG004","value":"81","spread":null},{"groupId":"OG005","value":"27","spread":null},{"groupId":"OG006","value":"91","spread":null},{"groupId":"OG007","value":"50","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"100","spread":null},{"groupId":"OG001","value":"67","spread":null},{"groupId":"OG002","value":"100","spread":null},{"groupId":"OG003","value":"83","spread":null},{"groupId":"OG004","value":"100","spread":null},{"groupId":"OG005","value":"76","spread":null},{"groupId":"OG006","value":"100","spread":null},{"groupId":"OG007","value":"78","spread":null}]}]}]},{"type":"SECONDARY","title":"Geometric Mean Titers (GMTs) With and Without Seasonal Influenza Vaccination for Year 2009 to 2010","description":"Subgroup analysis based on receipt of recent seasonal vaccination. Comparison between subjects previously vaccinated versus not vaccinated with seasonal influenza vaccines.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"11","spread":null},{"groupId":"OG001","value":"7.95","spread":null},{"groupId":"OG002","value":"9.94","spread":null},{"groupId":"OG003","value":"12","spread":null},{"groupId":"OG004","value":"10","spread":null},{"groupId":"OG005","value":"6.52","spread":null},{"groupId":"OG006","value":"8.30","spread":null},{"groupId":"OG007","value":"10","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"101","spread":null},{"groupId":"OG001","value":"25","spread":null},{"groupId":"OG002","value":"105","spread":null},{"groupId":"OG003","value":"42","spread":null},{"groupId":"OG004","value":"80","spread":null},{"groupId":"OG005","value":"17","spread":null},{"groupId":"OG006","value":"100","spread":null},{"groupId":"OG007","value":"45","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"975","spread":null},{"groupId":"OG001","value":"103","spread":null},{"groupId":"OG002","value":"788","spread":null},{"groupId":"OG003","value":"186","spread":null},{"groupId":"OG004","value":"389","spread":null},{"groupId":"OG005","value":"57","spread":null},{"groupId":"OG006","value":"483","spread":null},{"groupId":"OG007","value":"124","spread":null}]}]}]},{"type":"SECONDARY","title":"Antibody Response Based on Baseline Seropositivity","description":"Subgroup analysis based on Subjects with a pre-vaccination HI antibody titer \\< 1:10 and prevaccination HI antibody titer ≥ 1:10","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"72","spread":null},{"groupId":"OG001","value":"31","spread":null},{"groupId":"OG002","value":"82","spread":null},{"groupId":"OG003","value":"39","spread":null},{"groupId":"OG004","value":"77","spread":null},{"groupId":"OG005","value":"36","spread":null},{"groupId":"OG006","value":"74","spread":null},{"groupId":"OG007","value":"56","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"100","spread":null},{"groupId":"OG001","value":"67","spread":null},{"groupId":"OG002","value":"100","spread":null},{"groupId":"OG003","value":"77","spread":null},{"groupId":"OG004","value":"92","spread":null},{"groupId":"OG005","value":"71","spread":null},{"groupId":"OG006","value":"94","spread":null},{"groupId":"OG007","value":"74","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null},{"groupId":"OG001","value":"0","spread":null},{"groupId":"OG002","value":"0","spread":null},{"groupId":"OG003","value":"0","spread":null},{"groupId":"OG004","value":"62","spread":null},{"groupId":"OG005","value":"39","spread":null},{"groupId":"OG006","value":"54","spread":null},{"groupId":"OG007","value":"64","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"72","spread":null},{"groupId":"OG001","value":"31","spread":null},{"groupId":"OG002","value":"82","spread":null},{"groupId":"OG003","value":"39","spread":null},{"groupId":"OG004","value":"95","spread":null},{"groupId":"OG005","value":"57","spread":null},{"groupId":"OG006","value":"94","spread":null},{"groupId":"OG007","value":"74","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"100","spread":null},{"groupId":"OG001","value":"67","spread":null},{"groupId":"OG002","value":"100","spread":null},{"groupId":"OG003","value":"77","spread":null},{"groupId":"OG004","value":"100","spread":null},{"groupId":"OG005","value":"82","spread":null},{"groupId":"OG006","value":"100","spread":null},{"groupId":"OG007","value":"92","spread":null}]}]}]},{"type":"SECONDARY","title":"Geometric Mean Titers (GMTs) Based on Baseline Seropositivity","description":"Subgroup analysis based on Subjects with a pre-vaccination HI antibody titer \\< 1:10 and prevaccination HI antibody titer ≥ 1:10 Immunogenicity responses in subjects who are seropositive (A/H1N1 2009 HI titer ≥ 1:10) at Baseline (Day 1 (pre-vaccination)) as compared to those who are seronegative (HI titer \\< 1:10).","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"5.06","spread":null},{"groupId":"OG001","value":"5.07","spread":null},{"groupId":"OG002","value":"5.01","spread":null},{"groupId":"OG003","value":"5.06","spread":null},{"groupId":"OG004","value":"53","spread":null},{"groupId":"OG005","value":"35","spread":null},{"groupId":"OG006","value":"47","spread":null},{"groupId":"OG007","value":"69","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"42","spread":null},{"groupId":"OG001","value":"15","spread":null},{"groupId":"OG002","value":"60","spread":null},{"groupId":"OG003","value":"17","spread":null},{"groupId":"OG004","value":"266","spread":null},{"groupId":"OG005","value":"67","spread":null},{"groupId":"OG006","value":"313","spread":null},{"groupId":"OG007","value":"248","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"566","spread":null},{"groupId":"OG001","value":"65","spread":null},{"groupId":"OG002","value":"577","spread":null},{"groupId":"OG003","value":"96","spread":null},{"groupId":"OG004","value":"660","spread":null},{"groupId":"OG005","value":"167","spread":null},{"groupId":"OG006","value":"811","spread":null},{"groupId":"OG007","value":"420","spread":null}]}]}]},{"type":"SECONDARY","title":"Antibody Persistence by Geometric Mean Titers (GMT)","description":"Immunogenicity was assessed in terms of Geometric Mean Titers (GMT at 6 months (Day 202)and 12 months (Day 387) after second vaccination.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"10","spread":null},{"groupId":"OG001","value":"7.27","spread":null},{"groupId":"OG002","value":"9.29","spread":null},{"groupId":"OG003","value":"11","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"176","spread":null},{"groupId":"OG001","value":"33","spread":null},{"groupId":"OG002","value":"205","spread":null},{"groupId":"OG003","value":"42","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"92","spread":null},{"groupId":"OG001","value":"15","spread":null},{"groupId":"OG002","value":"85","spread":null},{"groupId":"OG003","value":"25","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":5,"n":162},"commonTop":["Irritability","Upper respiratory tract infection","Injection site pain","Diarrhoea","Pyrexia"]}}}